{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:55:26Z","timestamp":1767992126957,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1002\/rth2.12838","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T05:43:39Z","timestamp":1669959819000},"page":"e12838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity\u2010matched analysis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-6136","authenticated-orcid":false,"given":"Stevan S.","family":"Pupovac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-3194","authenticated-orcid":false,"given":"Pey\u2010Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12838_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1537-2995.2007.01573.x","article-title":"A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery","volume":"48","author":"Despotis","year":"2008","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12838_bb0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jtcvs.2009.02.021","article-title":"Costs of excessive postoperative hemorrhage in cardiac surgery","volume":"138","author":"Christensen","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12838_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","article-title":"The independent association of massive blood loss with mortality in cardiac surgery","volume":"44","author":"Karkouti","year":"2004","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12838_bb0025","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"115","author":"Murphy","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/rth2.12838_bb0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ejcts\/ezt662","article-title":"Coronary artery bypass grafting\u2010related bleeding complications in real\u2010life acute coronary syndrome patients treated with clopidogrel or ticagrelor","volume":"46","author":"Hansson","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12838_bb0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (platelet inhibition and patient outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/rth2.12838_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCULATIONAHA.108.764308","article-title":"Comprehensive Canadian review of the off\u2010label use of recombinant activated factor VII in cardiac surgery","volume":"118","author":"Karkouti","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/rth2.12838_bb0045","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.athoracsur.2004.09.034","article-title":"Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery","volume":"79","author":"Halkos","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12838_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","article-title":"Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score\u2010matched case\u2010control analysis","volume":"45","author":"Karkouti","year":"2005","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12838_bb0055","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.thromres.2015.10.032","article-title":"Activated prothrombin complex concentrate (FEIBA\u00ae) for the treatment and prevention of bleeding in patients with acquired haemophilia: a sequential study","volume":"136","author":"Zanon","year":"2015","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12838_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajh.21046","article-title":"Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature","volume":"83","author":"Leissinger","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1002\/rth2.12838_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/rth2.12838_bb0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/BF03022797","article-title":"Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery","volume":"53","author":"Karkouti","year":"2006","journal-title":"Can J Anesth"},{"key":"10.1002\/rth2.12838_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ACO.0b013e32831a40a3","article-title":"Efficacy and safety of activated recombinant factor VII in cardiac surgical patients","volume":"22","author":"Hardy","year":"2009","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1002\/rth2.12838_bb0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/jcan.2002.126927","article-title":"Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery","volume":"16","author":"von Heymann","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1002\/rth2.12838_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1503\/cmaj.071223","article-title":"Indication creep: physician beware","volume":"177","author":"Hebert","year":"2007","journal-title":"CMAJ"},{"key":"10.1002\/rth2.12838_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","article-title":"2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery","volume":"53","author":"Pagano","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12838_bb0095","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jtcvs.2013.11.020","article-title":"Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery","volume":"147","author":"Song","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12838_bb0100","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1540-8191.2008.00686.x","article-title":"Factor eight inhibitor bypassing activity (FEIBA) for refractory bleeding in cardiac surgery: review of clinical outcomes","volume":"23","author":"Balsam","year":"2008","journal-title":"J Card Surg"},{"key":"10.1002\/rth2.12838_bb0105","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-5223(97)70373-8","article-title":"Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study","volume":"113","author":"Ernofsson","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12838_bb0110","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/01.CIR.93.11.2014","article-title":"Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass","volume":"93","author":"Chung","year":"1996","journal-title":"Circulation"},{"key":"10.1002\/rth2.12838_bb0115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00000539-200205000-00070","article-title":"Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery","volume":"94","author":"Dietrich","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1002\/rth2.12838_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0032-1309286","article-title":"FEIBA: a prohemostatic agent","volume":"38","author":"Cromwell","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12838_bb0125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2006-04-017988","article-title":"A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven comparative (FENOC) study","volume":"109","author":"Astermark","year":"2007","journal-title":"Blood"},{"key":"10.1002\/rth2.12838_bb0130","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1182\/blood-2010-10-313973","article-title":"The incidence, risk factors, and outcome of transfusion\u2010related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case\u2010control study","volume":"117","author":"Vlaar","year":"2011","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12838","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12838","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922024335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922024335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:25:32Z","timestamp":1762863932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922024335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2475037922024335"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12838","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity\u2010matched analysis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis (ISTH)","name":"copyright","label":"Copyright"}],"article-number":"e12838"}}